Logo Image
News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsShortsSpecial ReportsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Hidradenitis Suppurativa
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Central Precocious Puberty
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Disorders
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • RSV
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Rare Disease
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement
|Articles|May 1, 2004

New index measures the well-being of the nation's children

Advertisement
Advertisement

Related Content

Advertisement
Infliximab, steroids may outperform anakinra for IVIG-resistant MIS-C | Image Credit: © Bernard Chantal - stock.adobe.com

Infliximab, steroids may outperform anakinra for IVIG-resistant MIS-C

ByMorgan Ebert, Executive Editor
August 19th 2026
FDA accepts ecopipam NDA with priority review for pediatric Tourette syndrome

FDA accepts ecopipam NDA with priority review for pediatric Tourette syndrome

ByMorgan Ebert, Executive Editor
August 19th 2026

Managing AD Flares and Debunking the Food Allergy Myth

ByLisa Swanson, MD, Ada West Dermatology
August 19th 2026

Misdiagnosis Pitfalls and the Hidden Consequences of Uncontrolled AD

ByLisa Swanson, MD, Ada West Dermatology
August 19th 2026
Early antiviral therapy linked to 81% lower influenza hospitalization risk in children | Image Credit: © pingpao - stock.adobe.com.

Early antiviral therapy linked to 81% lower influenza hospitalization risk in children

ByMorgan Ebert, Executive Editor
August 18th 2026
Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

FDA accepts ecopipam NDA with priority review for pediatric Tourette syndrome

2

Infliximab, steroids may outperform anakinra for IVIG-resistant MIS-C

3

Managing AD Flares and Debunking the Food Allergy Myth

4

Early antiviral therapy linked to 81% lower influenza hospitalization risk in children

5

Social media linked to riskier product use in teens

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us